Historically, multinational corporations and research institutions from developed nations harvested genetic resources and traditional knowledge from biodiverse developing countries without providing equitable returns. This economic imbalance led to international demands for a legally binding treaty to protect sovereign biological assets and eradicate corporate exploitation.
Defining the Nagoya Protocol
The Nagoya Protocol is a supplementary agreement to the Convention on Biological Diversity (CBD). It provides a transparent, legally binding international framework for the effective implementation of one of the three core pillars of the CBD: the fair and equitable sharing of benefits arising out of the utilization of genetic resources.
Background and Core Objectives
The Inception: The treaty was formally adopted on October 29, 2010, at the 10th Conference of the Parties (COP 10) in Nagoya, Japan, and officially entered into force on October 12, 2014.
Primary Objectives:
- To establish legal certainty and transparency for both providers and users of genetic resources.
- To implement structural mechanisms for Access and Benefit Sharing UPSC syllabus details emphasize.
- To ensure that traditional knowledge associated with genetic resources is accessed only with the prior consent of indigenous communities.
The Nagoya Protocol and the Elimination of Biopiracy
Biopiracy occurs when indigenous biological resources or traditional medicinal knowledge are patented or commercially exploited by external entities without permission from the native country or community.
The Nagoya Protocol acts as a structural defense against biopiracy by shifting the balance of power back to source nations. It mandates that any research institution or pharmaceutical giant seeking to exploit a native plant, animal, or microbe must enter into a formal, binding contract with the host country, ensuring that the local community receives a fair share of profits, technology, or intellectual rights.
Key Features of the Nagoya Protocol
The operational framework of the protocol rests on three core pillars:
A. Access Obligations
Nations have sovereign rights over their genetic assets. The protocol mandates that users must obtain Prior Informed Consent (PIC) from the provider country before accessing any biological resource or associated traditional knowledge.
B. Benefit-Sharing Obligations
Users and provider countries must negotiate Mutually Agreed Terms (MAT). These agreements specify exactly how benefits will be shared, split into two major streams:
- Monetary Benefits: Royalties, milestone payments, research funding, and joint venture profits.
- Non-Monetary Benefits: Technology transfers, capacity building, sharing research results, and training local scientists.
C. Compliance Obligations
The protocol requires signatory nations to establish internal domestic laws to ensure that any genetic material used within their borders was acquired in full compliance with the PIC and MAT requirements of the provider country.
India and the Nagoya Protocol
India is a leading megadiverse country and a proactive party to the protocol, having ratified it in 2012. India’s domestic implementation serves as a model for developing nations:
- Statutory Foundation: India anticipated these international standards by enacting the Biological Diversity Act, 2002 and setting up the Biological Diversity Rules, 2004.
- Institutional Tier: Governed by a decentralized three-tier structure:
National Biodiversity Authority (NBA): The apex statutory body based in Chennai that reviews and approves international access requests.
State Biodiversity Boards (SBBs): Regulate commercial utilization at the state level.
Biodiversity Management Committees (BMCs): Formed at the local panchayat level to document traditional knowledge via People’s Biodiversity Registers (PBRs).
Cartagena Protocol vs. Nagoya Protocol
Candidates must clearly distinguish between these two separate agreements under the parent CBD framework:
| Feature | Cartagena Protocol | Nagoya Protocol |
| Core Theme | Biosafety and environmental containment. | Access and Benefit Sharing (ABS). |
| Primary Target | Safe handling of Living Modified Organisms (LMOs and GMOs). | Fair utilization of natural genetic resources and traditional knowledge. |
| Operational Tool | Advance Informed Agreement (AIA). | Prior Informed Consent (PIC) & Mutually Agreed Terms (MAT). |
Implementation Challenges and Conclusion
A major structural challenge facing the protocol is the rise of Digital Sequence Information (DSI). Modern scientists no longer need to physically transport a rare plant across borders; they can simply sequence its DNA, upload the digital code online, and synthesize its compounds anywhere globally, bypassing traditional ABS contracts.
In conclusion, for a high-scoring strategy in the Nagoya Protocol UPSC segment, candidates must emphasize that biodiversity conservation cannot succeed without social justice. The Nagoya Protocol ensures that indigenous populations are recognized as rightful owners of their natural heritage, making it an indispensable pillar of modern environmental governance.
UPSC Prelims: PYQs & Practice Questions
Previous Year Questions (Prelims)
UPSC CSE Prelims 2023
Q: Consider the following statements:
1. In India, the Biodiversity Management Committees are key to the realization of the objectives of the
Nagoya Protocol.
2. The Biodiversity Management Committees have important functions in determining
Access and Benefit Sharing, including power to levy collection fees on the access of biological resources within its jurisdiction.
Which of the statements given above is/are correct?
(a) 1 only
(b) 2 only
(c) Both 1 and 2
(d) Neither 1 nor 2
Answer: (c) Both 1 and 2
Explanation:
Both statements are correct. In India,
Biodiversity Management Committees (BMCs) are established at the local body level under the
Biological Diversity Act, 2002.
They play a critical role in fulfilling the objectives of the Nagoya Protocol by documenting biological resources and traditional knowledge through People’s Biodiversity Registers (PBRs). Under Section 41 of the Act, BMCs are empowered to support local access regulation and levy collection fees on persons accessing biological resources for commercial use within their jurisdiction.
UPSC CSE Prelims 2011
Q: Consider the following statements:
1. The Cartagena Protocol on Biosafety is an international treaty governing the movements of
living modified organisms (LMOs) resulting from modern biotechnology from one country to another.
2. The Nagoya Protocol on Access and Benefit Sharing is a supplementary agreement to the
Convention on Biological Diversity (CBD).
Which of the statements given above is/are correct?
(a) 1 only
(b) 2 only
(c) Both 1 and 2
(d) Neither 1 nor 2
Answer: (c) Both 1 and 2
Explanation:
Both statements are correct. They refer to two major supplementary protocols under the parent framework of the
Convention on Biological Diversity (CBD).
The Cartagena Protocol, adopted in 2000, deals with biosafety and transboundary movement of Living Modified Organisms (LMOs). The Nagoya Protocol, adopted in 2010, provides the framework for Access and Benefit Sharing (ABS) arising from the use of genetic resources and associated traditional knowledge.
Practice Questions
Q: In the context of international environmental law under the Nagoya Protocol, consider the following statements regarding Digital Sequence Information (DSI):
1. DSI refers to the digitized genetic sequence data of a biological resource, allowing scientists to access and synthesize molecular compounds without physically moving a plant or organism across borders.
2. The original text of the Nagoya Protocol, 2010 contains explicit, legally binding provisions that automatically apply traditional benefit-sharing rules to open-access digital DNA databases.
Which of the statements given above is/are correct?
(a) 1 only
(b) 2 only
(c) Both 1 and 2
(d) Neither 1 nor 2
Answer: (a) 1 only
Explanation:
Statement 1 is correct. Digital Sequence Information (DSI) refers to digitized genetic sequence data of biological resources. It allows researchers and companies to use genetic blueprints without physically transporting biological material across borders.
Statement 2 is incorrect. DSI is considered a major regulatory challenge because the original Nagoya Protocol, 2010 mainly dealt with physical access to genetic resources. Whether DSI should be brought under Access and Benefit Sharing (ABS) rules remains a major debate in recent CBD negotiations.
Q: Under India’s domestic execution of Nagoya Protocol mandates, an international pharmaceutical firm must secure statutory clearance from which apex authority before accessing a native Indian herb for commercial drug development?
(a) Ministry of Commerce and Industry
(b) Genetic Engineering Appraisal Committee (GEAC)
(c) National Biodiversity Authority (NBA)
(d) Wildlife Crime Control Bureau (WCCB)
Answer: (c) National Biodiversity Authority (NBA)
Explanation:
The National Biodiversity Authority (NBA), established under the
Biological Diversity Act, 2002, is India’s apex statutory body for regulating access to Indian biological resources by foreign individuals, companies, or institutions.
Any foreign entity seeking to access India’s biological resources or associated traditional knowledge for research, commercial use, bio-survey, bio-utilization, or patent filing must obtain prior approval from the NBA. This helps India implement the Access and Benefit Sharing objectives of the Nagoya Protocol.
UPSC Mains – Previous Year & Practice Questions
Mains Previous Year Questions
Mains 2018
Question: How does biodiversity vary in India?
How is the Biological Diversity Act, 2002 helpful in conservation of flora and fauna?
(Requires linking the domestic Act directly to the international benefit-sharing obligations mandated by Nagoya.)
Mains 2023
Question: Identify the main causes of the loss of
biodiversity in India.
(Can discuss how biopiracy and underfunded local conservation networks accelerate habitat fragmentation.)
Mains 2020
Question: How does the draft
Environment Impact Assessment (EIA) Notification differ from the existing
EIA Notification, 2006?
(Useful for connecting clearance norms with ecological safeguards, local consent, and protection of biodiversity-rich areas.)
Mains 2014
Question: Enumerate the
indirect services provided by an ecosystem.
How do wetlands act as “Earth’s Kidneys”?
(Can be linked to ecosystem services, genetic resources, and benefit-sharing under biodiversity governance.)
Mains 2015
Question: What are the main bottlenecks in the adoption of
genetically modified (GM) crops in India?
(Useful for contrasting the biosafety focus of Cartagena with the commercial equity focus of the Nagoya Protocol.)
Mains Practice Questions
[10 Marks | 150 Words]
Question: Define “Biopiracy”. Explain how the Nagoya Protocol acts as a structural defense mechanism for indigenous communities protecting their sovereign genetic heritage.
[15 Marks | 250 Words]
Question: Analyze the three-tier decentralized architecture established under India’s Biological Diversity Act, 2002. Assess its effectiveness in enforcing the Access and Benefit Sharing (ABS) mandates of the Nagoya Protocol at the grassroots level.
[15 Marks | 250 Words]
Question: The rise of Digital Sequence Information (DSI) threatens to make the traditional physical frameworks of the Nagoya Protocol obsolete. Critically evaluate the regulatory challenges DSI poses to international environmental governance.
Nagoya Protocol-FAQs
What is Access and Benefit Sharing in simple terms?
ABS means if a company uses a country’s biological resource or traditional knowledge, it must share benefits fairly. These benefits may include profits, technology, training, or conservation support.
Difference between PIC and MAT?
PIC means prior permission from the provider country before accessing biological resources. MAT means the agreed contract explaining how benefits, profits, or research outcomes will be shared.
How does India protect traditional knowledge from foreign patents?
India uses the Traditional Knowledge Digital Library to record Ayurveda, Unani, and Siddha knowledge. It helps patent offices identify prior art and reject false patent claims.
Why is Digital Sequence Information a challenge to Nagoya Protocol?
DSI allows genetic data to be shared digitally without moving physical biological samples. This can help companies bypass benefit-sharing duties linked to the original country.
